alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 32

CERTIFICATION PURSUANTTO 

SECTION 906 OF THESARBANES-OXLEY ACT OF 2002 

(18 U.S.C. SECTION1350)

 

In connection withthe Quarterly Report of First National Power Corporation, a Delaware corporation(the "Company"), on Form 10-QSB for the quarter ending March 31, 2004 as filedwith the Securities and Exchange Commission (the "Report"), I, DarrylMills, President of the Company, certify, pursuant to Section 906 of theSarbanes-Oxley Act of 2002 (18 U.S.C. Section 1350), that to my knowledge: 

 

(1) The Report fullycomplies with the requirements of section 13(a) or 15(d) of the SecuritiesExchange Act of 1934; and 

 

(2) The informationcontained in the Report fairly presents, in all material respects, the financialcondition and result of operations of the Company. 

 

 

_______________________________

Darryl Mills, President

Dated: ________________________

 

 

 

 

CERTIFICATION PURSUANTTO 

SECTION 906 OF THESARBANES-OXLEY ACT OF 2002 

(18 U.S.C. SECTION1350)

 

In connection withthe Quarterly Report of First National Power Corporation, a Delaware corporation(the "Company"), on Form 10-QSB for the quarter ending March 31, 2004 as filedwith the Securities and Exchange Commission (the "Report"), I, Peter Wanner,Chief Financial Officer of the Company, certify, pursuant to Section 906 of theSarbanes-Oxley Act of 2002 (18 U.S.C. Section 1350), that to my knowledge: 

 

(1) The Report fullycomplies with the requirements of section 13(a) or 15(d) of the SecuritiesExchange Act of 1934; and 

 

(2) The informationcontained in the Report fairly presents, in all material respects, the financialcondition and result of operations of the Company. 

 

 

_______________________________

Peter Wanner, Chief Financial Officer

Dated: ________________________
```

[Congressional Record Volume 158, Number 129 (Friday, September 21, 2012)]
[House]
[Page H6257]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

                     CONGRESS SHOULD STAY AND WORK

  (Mr. LARSON of Connecticut asked and was given permission to address 
the House for 1 minute and to revise and extend his remarks.)
  Mr. LARSON of Connecticut. Mr. Speaker, one of my constituents wrote 
very emphatically: How could Congress possibly leave when they know 
that we the people face the deep, dark abyss of uncertainty--
uncertainty about our unemployment, uncertainty about the jobs that we 
need, the uncertainty that comes when your mortgage is under water, the 
uncertainty that comes when you know that you have to educate your 
children, and yet Congress leaves without addressing the basic needs of 
the people that we're sworn to serve.
  For the last week, we've heard an awful lot about work requirements. 
The primary work requirement that should be asked is of this United 
States Congress, for it to stay and do the work of the people. There is 
a jobs bill that's out there. There are tax cuts that can be achieved. 
Let's stay and do that work.

                          ____________________
```
Court of Appeals of the State of Georgia Clerk's Office, Atlanta, July 19, 2017. I certify that the above is a true extract from the minutes of the Court of Appeals of Georgia. Witness my signature and the seal of said court hereto affixed the day and year last above written. , Clerk. 

# Court of Appeals of the State of Georgia
ATLANTA, July 19, 2017 The Court of Appeals hereby passes the following order A17I0261. KEVIN JAMES DAVIS v. THE STATE. Upon consideration of the Application for Interlocutory Appeal, it is ordered that it be hereby DENIED.
LC NUMBERS: CR152664
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
 WASHINGTON, DC 20549
 FORM 8-K
 CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
 Date of report (Date of earliest event reported): July 14, 2008
 
 PACIFIC SUNWEAR OF CALIFORNIA, INC.
 (Exact Name of Registrant as Specified in Charter)
 California
    
    0-21296
    
    95-3759463(State or Other Jurisdiction of Incorporation)
    
    (Commission File Number)
    
    (IRS EmployerIdentification No.)3450 East Miraloma Avenue
    
    
    
    92806-2101Anaheim, CA
    
    
    
    (Zip Code)(Address of principal executive offices)
 (714) 414-4000
Registrants telephone number, including area code
 
  o
 o
 o
 o




---



##### 



Item 7.01 Regulation FD Disclosure.




---



##### 



SIGNATURE
  Dated:  July 24, 2008
    Pacific Sunwear of California, Inc./s/ Sally Frame KasaksSally Frame KasaksChief Executive Officer
----

            DECISION OF THE EEA JOINT COMMITTEE         

No 95/2006

of 7 July 2006         

amending Annex XXI (Statistics) to the EEA Agreement

THE EEA JOINT COMMITTEE,

Having regard to the Agreement on the European Economic Area, as amended by the Protocol adjusting the Agreement on the European Economic Area, hereinafter referred to as ‘the Agreement’, and in particular Article 98 thereof,

Whereas:

HAS DECIDED AS FOLLOWS:

Article 1

The following point shall be inserted after point 4ac (Commission Regulation (EC) No 912/2004) of Annex XXI to the Agreement:

Article 2

The text of Regulation (EC) No 317/2006 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.

Article 3

This Decision shall enter into force on 8 July 2006, provided that all the notifications under Article 103(1) of the Agreement have been made to the EEA Joint Committee (*1).

Article 4

This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.

Done at Brussels, 7 July 2006.

For the EEA Joint Committee

The President

Oda Helen SLETNES            

----

(1)OJ L 245, 7.9.2006, p. 42.

(2)OJ L 60, 1.3.2006, p. 1.

(*1)  No constitutional requirements indicated.

----
<PAGE>


                                                                  EXHIBIT 23.1


                          CONSENT OF INDEPENDENT ACCOUNTANTS


We hereby consent to the incorporation by reference in these Registration
Statements on Form S-8 (File Nos. 33-71266, 33-71776, 33-72166, 33-86982,
333-03845, 333-42183, 333-53915 and 333-53917) of The J. Jill Group, Inc. and
subsidiary of our report dated February 14, 2000 relating to the financial
statements, which appears in the Annual Report to Shareholders, which is
incorporated in this Annual Report on Form 10-K. We also consent to the
incorporation by reference of our report dated February 14, 2000 relating to
the financial statement schedule, which appears in this Form 10-K.

PricewaterhouseCoopers LLP

Boston, Massachusetts
March 23, 2000
----

            COMMISSION DECISION         

of 13 November 2006         

amending Annex D to Council Directive 95/70/EC as regards the list of exotic mollusc diseases subject to harmonised Community control measures

(notified under document number C(2006) 5309)

(Text with EEA relevance)

(2006/775/EC)

THE COMMISSION OF THE EUROPEAN COMMUNITIES,

Having regard to the Treaty establishing the European Community,

Having regard to Council Directive 95/70/EC of 22 December 1995 introducing minimum Community measures for the control of certain diseases affecting bivalve molluscs (1), and in particular Article 9 thereof,

Whereas:

HAS ADOPTED THIS DECISION:

Article 1

Annex D to Directive 95/70/EC is replaced by the text in the Annex to this Decision.

Article 2

This Decision is addressed to the Member States.

Done at Brussels, 13 November 2006.

For the Commission

Markos KYPRIANOU            

Member of the Commission

----

(1)OJ L 332, 30.12.1995 p. 33. Directive as last amended by the 1993 Act of Accession.

(2)OJ L 46, 19.2.1991, p. 1. Directive as last amended by Regulation (EC) No 806/2003 (OJ L 122, 16.5.2003 p. 1).

(3)  Not yet published in the Official Journal.

----

ANNEX

                     ‘ANNEX D

----
Exhibit 23.1Consent of Independent Registered Public Accounting FirmWe consent to the reference to our firm under the caption “Experts” and to the use of our reportdated September 26, 2007, with respect to the consolidated financial statements of Peplin Limitedincluded in Amendment No. 1 to the Registration Statement (Form S-1 No. 333-145266) and relatedProspectus of Peplin, Inc. expected to be filed on or about September 28, 2007./s/ Ernst & Young
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS
ADOPTED PURSUANT TO SECTION 906


OF THE SARBANES-OXLEY ACT OF 2002





In connection with the annual report of microHelix, Inc.
(the "Company") on Form 10-Q for the three months ended March 31, 2007 as filed
with the Securities and Exchange Commission on the date hereof (the "Report"),
I, James E. Horswill,Presidentand Chief Financial Officer of the Company, certify
pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that:


1.
              The Report fully complies with the requirements of
      Section 13(a) or 15(d) of the Securities Exchange Act of 1934;
      and
 
 2.
              The information contained in the Report fairly
      presents, in all material respects, the financial condition and results of
      operations of the
Company.





Date:March 24, 2009





/s/ James E. Horswill


James E. Horswill


Presidentand Chief
Financial Officer
##### 



EXHIBIT 21

SUBSIDIARIES OF THE REGISTRANT

|                                                                                                                                                                                                                                            |                                             |                                                                                                             
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | ------------------------------------------- | ------------------------------------------------------------------------------------------------------------
|Subsidiary                                                                                                                                                                                                                                  | State or Country of Incorporation/Formation
|Digene B.V.
Digene do Brasil LTDA
Digene Europe, Inc.
Digene (Switzerland) Sarl
Digene UK (Holdings) Limited
Digene Diagnostics, S.L.*
Digene Deutschland GmbH*
Digene (France) S.A.S.*
Digene Italia SRL*
Digene UK Limited*
Viropath B.V. |                                             | Netherlands
Brazil
Delaware
Switzerland
United Kingdom
Spain
Germany
France
Italy
United Kingdom
Netherlands



---

|* |  | Wholly owned subsidiary of Digene UK (Holdings) Limited
|- |  | -------------------------------------------------------
EXHIBIT 11


 US DIAGNOSTIC INC. AND SUBSIDIARIES
--------------------------------------------------------------------------------

--------------------------------------------------------------------------------

<TABLE>
<CAPTION>
                                                                YEAR ENDED              YEAR ENDED
                                                                   1996                   1995
                                                                ----------              ---------

                                                             (IN THOUSANDS, EXCEPT PER SHARE AMOUNTS)
PRIMARY EARNINGS PER SHARE:
<S>                                                              <C>                     <C>
Primary Weighted Average Shares of Common Stock
and Common Stock Equivalents Outstanding                           13,576                  4,996
                                                                 ========                =======

Net Income (Loss)                                                $ (6,331)               $ 3,331
                                                                 ========                =======

Earnings (Loss) Per Share - Primary                              $   (.47)               $   .67
                                                                 ========                =======

FULLY DILUTED EARNINGS PER SHARE: (1)

Weighted Average Shares Outstanding                                13,576                  4,996
Dilutive Effect of Assumed Warrant Conversions                     10,886                  7,182
                                                                 --------                -------

Fully Diluted  Weighted  Average Shares of Common Stock
and Common Stock Equivalents Outstanding                           24,462                 11,761
                                                                 ========                =======

Net Income (Loss)                                                $ (6,331)               $ 3,331

Adjustments to Net Income for Interest Savings                      2,837                  3,682
                                                                 --------                -------

Adjusted Net Income (Loss)                                       $ (3,494)               $ 7,013
                                                                 ========                =======

Earnings (Loss) Per Share - Fully Diluted                        $   (.14)               $   .60
                                                                 ========                =======
<FN>
----------
(1)  This calculation is submitted for 1996 in accordance with Regulation S-K
     Item 601(b)(11) although it is contrary to paragraph 40 of APB Opinion No.
     15 because it produces an anti-dilutive result.
</FN>
</TABLE>
```

[Federal Register: March 15, 2010 (Volume 75, Number 49)]
[Notices]               
[Page 12328]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr15mr10-104]                         

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Office of the Secretary

 
Application of Charter Air Transport, Inc. for Commuter Authority

AGENCY: Department of Transportation.

ACTION: Notice of Order to Show Cause (Order 2010-3-8); Docket DOT-OST-
2009-0187.

-----------------------------------------------------------------------

SUMMARY: The Department of Transportation is directing all interested 
persons to show cause why it should not issue an order finding Charter 
Air Transport, Inc., fit, willing, and able, and awarding it Commuter 
Air Carrier Authorization.

DATES: Persons wishing to file objections should do so no later than 
(insert date 5 business days from publication).

ADDRESSES: Objections and answers to objections should be filed in 
Docket DOT-OST-2009-0187 and addressed to U.S. Department of 
Transportation, Docket Operations, (M-30, Room W12-140), 1200 New 
Jersey Avenue, SE., West Building Ground Floor, Washington, DC 20590, 
and should be served upon the parties listed in Attachment A to the 
order.

FOR FURTHER INFORMATION CONTACT: Vanessa Balgobin, Air Carrier Fitness 
Division (X-56, Room W86-467), U.S. Department of Transportation, 1200 
New Jersey Avenue, SE., Washington, DC 20590, (202) 366-9721.

Susan L. Kurland,
Assistant Secretary for Aviation and International Affairs.
[FR Doc. 2010-5555 Filed 3-12-10; 8:45 am]
BILLING CODE P
```
EXHIBIT 32



<PAGE>



     In connection  with the Annual Report of ONTV, Inc. (the "Company") on Form
10-KSB for the period  ending  June 30,  2005 as filed with the  Securities  and
Exchange  Commission  (the  "Report"),  Daniel M.  Fasano,  the Chief  Executive
Officer and Chief Financial  Officer of the Company,  certifies,  pursuant to 18
U.S.C.  Section 1350, as adopted  pursuant to Section 906 of the  Sarbanes-Oxley
Act of 2002, that to the best of his knowledge:

(1)  The Report fully complies with the  requirements  of Section 13(a) or 15(d)
     of the Securities Exchange Act of 1934; and

(2)  The information  contained in the Report fairly  presents,  in all material
     respects the financial condition and results of the Company.


                             By /s/ Daniel M. Fasano
                                --------------------------------------
                                Daniel M. Fasano, Chief Executive and Principal
                                Financial Officer

October 31, 2005
32.1 SECTION 1350 CERTIFICATION OF CHIEF EXECUTIVE OFFICER


CERTIFICATION OF CHIEF EXECUTIVE OFFICER


PURSUANT TO 18 U.S.C. SECTION 1350,


AS ADOPTED PURSUANT TO


SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002




In connection with the Quarterly Report of Commonwealth Income & Growth Fund IV, (the “Company”) on Form 10-Q for the quarter ended March 31, 2011, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Kimberly A. Springsteen-Abbott, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:




(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and




(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.




/s/Kimberly A. Springsteen-AbbottKimberly A. Springsteen-AbbottChief Executive OfficerMay 13, 2011
```

[Congressional Record Volume 158, Number 123 (Thursday, September 13, 2012)]
[Extensions of Remarks]
[Pages E1519-E1520]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

                     RECOGNIZING DR. NEAL A. YOUNG

                                  _____
                                 

                       HON. ELEANOR HOLMES NORTON

                      of the district of columbia

                    in the house of representatives

                      Thursday, September 13, 2012

  Ms. NORTON. Mr. Speaker, I rise today to recognize the 
accomplishments of District of Columbia resident Dr. Neal A. Young, 
recipient of the 2012 Samuel J. Heyman Service to America Medal for 
Science and Environment. These prestigious awards, presented annually 
by the Partnership for Public Service, honor outstanding achievements 
by federal employees in nine categories.
  Dr. Young is the Chief of the Hematology Branch, National Heart, Lung 
and Blood Institute at the National Institutes of Health (NIH) and the 
director of the NIH Center for Human

[[Page E1520]]

Immunology, Autoimmunity and Inflammation. His pioneering laboratory 
and clinical research, together with his clinical practice and 
mentoring, has saved the lives of thousands of people throughout the 
world suffering from bone marrow failure syndromes, all while serving 
as a federal employee. During his federal service, Dr. Young has become 
the world's foremost expert in the difficult area of bone marrow 
failure, and the treatment protocols he developed for aplastic anemia 
are considered best practice. Currently, Dr. Young, who developed 
methods for testing for the B19 parvovirus, has a vaccine for the virus 
in clinical trials. He also has dedicated himself to training the next 
generation of hematology clinicians-researchers, and his students have 
gone on to lead departments throughout the world. We are particularly 
pleased and proud that a scientist with Dr. Young's accomplishments is 
a resident of our city, where his example will especially inspire the 
budding young scientists among our children.
  At a time when many federal employees feel beleaguered, Dr. Young's 
award puts a face on the term ``federal employee.'' Earlier this year, 
I introduced H. Res. 682, which expresses the sense of the House of 
Representatives in support of our outstanding federal employees, who 
are the best educated and most highly qualified broadly based workforce 
in the country. Dr. Young is a distinguished representative of federal 
employees at every level, who give their best to their work for the 
American people. The residents of the District of Columbia, many of 
whom also are federal employees, join me in congratulating Dr. Young, a 
distinguished D.C. resident who exemplifies our high quality federal 
employees and is now honored by our nation as one of our most 
remarkable scientists.
  Mr. Speaker, I ask the House to join me in honoring Dr. Neal Young 
for his outstanding accomplishments in science and for his continuous 
commitment to public service.

                          ____________________
```
```

[Federal Register Volume 77, Number 134 (Thursday, July 12, 2012)]
[Notices]
[Pages 41165-41166]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-17015]

=======================================================================
-----------------------------------------------------------------------

COMMISSION ON CIVIL RIGHTS

Agenda and Notice of Public Meeting of the Arkansas Advisory 
Committee

    Notice is hereby given, pursuant to the provisions of the rules and 
regulations of the U.S. Commission on Civil Rights (Commission), and 
the Federal Advisory Committee Act (FACA), that a factfinding meeting 
of the Arkansas Advisory Committee to the Commission will convene on 
Wednesday, September 12, 2012 thru Thursday, September 13, 2012 and 
adjourn each day at approximately 5:00 p.m. (CST). The meeting will 
convene at University of Little Rock William H. Bowen School of Law 
Auditorium, 1201 McMath Avenue, Little Rock, AR 72202. The purpose of 
the meeting is to receive information from local, state and federal 
officials, community leaders and experts on whether or not there is a 
need for a state civil rights enforcement agency.
    Members of the public are entitled to submit written comments. The 
comments must be received in the regional office by October 12, 2012. 
The address is U.S. Commission on Civil Rights, 400 State Avenue, Suite 
908, Kansas City, Kansas 66101. Persons wishing to email their 
comments, or to present their comments verbally at the meeting, or who 
desire additional information should contact Farella E. Robinson, 
Regional Director, Central Regional Office, at (913) 551-1400, (or for 
hearing impaired TDD 913-551-1414), or by email to frobinson@usccr.gov.
    Hearing-impaired persons who will attend the meeting and require 
the services of a sign language interpreter should contact the Regional 
Office at least ten (10) working days before the scheduled date of the 
meeting.
    Records generated from this meeting may be inspected and reproduced 
at the Central Regional Office, as they become available, both before 
and after the meeting. Persons interested in the work of this advisory 
committee are advised to go to the Commission's Web site, 
www.usccr.gov, or to contact the Central Regional Office at the above 
email or street address.

[[Page 41166]]

    The meeting will be conducted pursuant to the provisions of the 
rules and regulations of the Commission and FACA.

    Dated in Washington, DC, July 9, 2012.
Peter Minarik,
Acting Chief, Regional Programs Coordination Unit.
[FR Doc. 2012-17015 Filed 7-11-12; 8:45 am]
BILLING CODE 6335-01-P
```